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TheCD4 glycoprotein is expressed on the surface ofmature T lymphocytes that
recognize foreign peptide antigens bound to class IIMHC molecules . CD4has been
shown to play an important role in stimulatingT cell responses to antigen, most
likely by acting as an adhesion molecule and by enhancing signal transduction
(reviewed in references 1, 2) . There is strong evidence that CD4 is a receptor for
a relatively conserved region on class II proteins (3-6). We have previously shown
that expression of a transfected mouseCD4 (mCD4) t construct markedly enhances
the IL-2 response ofa beef insulin-specific mouseT helper cell hybridoma to beef
insulin and results in a new response to pork insulin (7) . We have now examined
the potential interactions between humanCD4 (hCD4) and mouse class II mole-
cules by transfection ofahCD4 construct into this mouse hybridoma. We find that
hCD4 is as effective as mCD4 in stimulating responses to beef and pork insulin
presentedbymouse class II molecules on transfected mouseL cells . These responses
are specific for hCD4, since they are blocked by specific mAbs and by the gp120
envelope glycoprotein fromHIV1 . These data imply that hCD4 can interact func-
tionally with mouse class IIMHC molecules. This finding further distinguishes the
interaction between gp120 and CD4 from that between mouse class II molecules
andCD4, since gp120 only binds to hCD4 (8) and notmCD4 (9), while mouse class
II molecules interact with CD4 from either species.
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Materials and Methods
Reagents.
￿
Beef and pork insulin were purchased from Sigma Chemical Co. (St . Louis,
MO). G418 was purchased from Gibco Laboratories (Grand Island, NY) . FITC-conjugated
anti-Leu-3a and phycoerythrin(PE)-conjugatedanti-L3T4mAbs were obtained from Becton
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Dickinson & Co. (Mountain View, CA). mAb F23.1 (10), which is specific for Vf8, binds
to the S chain of the beef insulin-specific TCR of BI-141. mAb H10-2.16 (11) is specific for
the MHC restriction element I-Ak recognized by BI-141 (12). Both mAbs were used as cul-
ture supernatant. mAb GK1.5, which is specific for mouse CD4 (L3T4), was obtained from
American Type Culture Collection (Rockville, MD) (13). Purified OKT4B and OKT4DmAbs
were a gift from Ortho Diagnostic Systems Inc. (Raritan, NJ) and anti-Leu-3a was a gift
from Becton Dickinson & Co. As a secondary stage antibody Texas red (TR)-conjugated
rabbit anti-mouse Ig from Axell (Accurate Chemical & ScientificCorp., Westbury, NY) was
used. Recombinant soluble CD4 (sCD4) (14) and recombinant gp120 of HIV-1 (15) were a
gift from Genentech Inc. (South San Francisco, CA). Highly purified recombinant human
IL-2 from E. coli was a gift from Cetus Corp. (Emeryville, CA) and had a specific activity
of 18 x 106 IU/mg.
CellLines.
￿
The beefinsulin-specific T cell hybridoma BI-141 (7, 12) was cultured in com-
plete RPMI 1640 (Gibco Laboratories). FT5.7 is a transfected line ofmouse L cells expressing
cell surface mouse MHC class II A,!bAS' molecules (gift from R. Germain) and was grown
in complete DME. The IL-2-dependent T cell line HT-2 (16) was maintained in complete
RPMI containing 10 IU/ml recombinant human IL-2. Complete culture medium consisted
of RPMI 1640 or DME (Gibco Laboratories) supplemented with 1 mM sodium pyruvate,
10 mM Hepes (Applied Scientific, San Francisco, CA), 2 MM L-glutamine (Irvine Scientific,
Santa Ana, CA), penicillin (100 U/ml), streptomycin (100 log/ml) (Flow Laboratories Inc,
McLean, VA) and 107o heat-inactivated FCS (Gemini Bio Products Inc., Calabasas, CA).
Expression of CD4 Genes in BI-141 Cells.
￿
BI-141 T cell hybridoma cells were transfected
by electroporation as described (17) with 3,500 V/cm using a Zapper ZA 1000 (Prototype
Design Services, Inc., Madison, WI) with one of two expression vectors, either pSFSVneo
(7) or pHOAPr-2-neo (18) containing a full-length cDNA encoding either human CD4 (19)
or mouse CD4 (20). Both vectors contain the bacterial gene conferring resistanceto neomycin,
so transfectants were selected by growth in the presence of 1.5 mg/ml (active concentration)
of the antibiotic G418.
Fluorescence Analysis.
￿
G418-resistant lines oftransfected BI-141 cells were analyzed for cell
surface expression of hCD4, mCD4, and TCR. Cells were stained at 4°C with F23.1 culture
supernatant for 30 min, washed twice, incubated with 1 :10 diluted TRconjugated rabbit
anti-mouse Ig at 4°C for an additional 30 min, washed twice again, and incubated with
1 :10 diluted FITC-conjugated anti-Leu-3a or PE-conjugated anti-L3T4 mAbs. 104 cells were
analyzed with a FAGS (Becton Dickinson & Co.) and dead cells were gated out of analysis.
FunctionalAnalysis of BI-141 Transfectants.
￿
FT5.7 cells were plated out at a concentration
of 105 cells/well in a 96-well flat-bottomed plate (Linbro; Flow Laboratories Inc., McLean,
VA) and incubated overnight with serial dilutions ofbeef or pork insulin in complete culture
medium. Free insulin was removed by washing with culture medium, and 105 responder cells
were added per well. Triplicate cultures were incubated in a final volume of 200,ul at 370C.
After 24 h 100 p,l of supernatant from each well were harvested and frozen. The thawed super-
natants were assayed for the presence of IL-2 by their ability to support the proliferation
of the IL-2-dependent line HT-2 (16). Proliferation was assessed by the incorporation of
[3H]thymidine (Amersham Corp., Arlington Heights, IL) during an 8-h pulse. Serial dilu-
tions ofrecombinant human IL-2 were used as a standard. The maximal response correlated
to 7 .2 IU/ml IL-2.
Inhibition Studies.
￿
For inhibition experiments with BI-141 control and transfected cells,
purified mAbs, recombinant gp120or sCD4 were added at the onset of cultures at indicated
concentrations. At the concentrations used these reagents did not have any effects on the
growth of the indicator cell line HT-2.
Results
BI-141 Transfectants Express Comparable Levels ofmCD4 and hCD4.
￿
The beef in-
sulin-specific mouse T helper hybridoma BI-141 (12) lacks cell surface expression
of mCD4 and uses a V08 TCR to respond to the antigen beef insulin in associationwith the mouse class II MHC molecule A.,bAsk. We have transfected this hy-
bridoma with full-length cDNA clones encoding either hCD4 or mCD4 in an ex-
pression vector. Transfectants expressing CD4 were then subcloned and analyzed
for cell surface expression of human or mouse CD4 and V08 (Fig. 1). V08 expres-
sion was comparable in non-transfected and in hCD4- or mCD4-transfected cells
(Fig. 1). Staining forhCD4 wassomewhat lower than that for mCD4, although this
may be a reflection of antibody affinity. The level of hCD4 expression was equal
to (BIT4.D3) or slightly lower than (BIT4.D1) that seen with the same mAbs on
human peripheral blood CD4' cells, while levels of mCD4 expression were slightly
higher than on mouse splenic CD4' cells (data not shown). Transfectants expressing
hCD4 were also examined for potential induction of mCD4 expression, but they
failed to stain with mAb GK1.5 (13), specific for mCD4.
hCD4 Enhances theAntigen-speck IL-2Production ofBI-141 Cells.
￿
Functional anal-
ysis ofthe hCD4-transfected T cell lines revealed a dramatic increase in IL-2 secre-
tion in response to beef insulin presented by A ,bAsk-transfected L cells as compared
with the parental BI-141 line (Fig. 2 a). A new reactivity to pork insulin was also
seen in the hCD4-transfected T cells (Fig. 2 b). For both antigens the enhanced re-
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FIGURE 1.
￿
Flowcytometric analysis ofTCR, hCD4, andmCD4
on BI-141 transfectants. The untransfected parental line, BI-141
(a, b) and mCD4 transfectants, BI-L3T4.5b (g, h), and BI-
L3T4D.B3 (i,J) were stained with antiTCR(F23.1) (a, g, :) and
anti-mCD4(GK1.5)(b, h,J) mAbs. hCD4 transfectants BIT4.D1
(c, d) and BIT4.D3 (e, f) were stained with antiTCR (F23.1)(c,
e) and anti-hCD4 (Leu-3a) (d,J) mAbs.
cc
m BI-74.133
i t !! I<
z
J I f iF23.1
U
i~
W
Q BI-L3T4.5b1882 EQUIVALENCE OF HUMAN AND MOUSE CD4 IN A MOUSE SYSTEM
a
100
0
E
u
sponsiveness ofThybridomalines expressing hCD4 was indistinguishable from that
oftransfectants expressing mCD4 (Fig. 2). Similarresultswere found whenantigen
was presented by irradiated spleen cells of (B10 x B10.BR)F, mice, which also ex-
press the appropriate class II MHC molecule (data not shown).
Specific Blocking ofhCD4 Transfectantsby mAbs.
￿
Toprovethat the enhanced respon-
siveness ofthe hCD4 transfectants was a result offunctional interactions involving
hCD4, we examined the effects oftreatment ofthe transfectants with mAbs specific
for hCD4. As shown in Figs. 3 and 4, antigen responses by transfectants expressing
hCD4 could be inhibited by mAbs specific for hCD4 (OKT4B and OKT4D), but
not by mAb GK1.5 specific for mCD4. Anti-hCD4 mAb Leu-3a was also found to
FIGURE 2.
￿
Expression ofhCD4 increases the re-
sponse ofBI-141 cells to antigen on mouse APCs.
T hybridoma cells (105) were cocultured with 105
FT5.7 APCs pulsed with varyingconcentrations
of beef(a) or pork (b) insulin. BI-141 (CD4-) (O
and "), BIT4.D3 (hCD4') (p), BIT4.D1
(hCD4') (/), BI-L3T4.56 (mCD4') (A) and
BI-L3T4D.B3 (mCD4') (A).
BI-141
￿
BI-141 BI-LM4.56 BI-L3T4D.B3 BI-T4.D3 BI-T4.Dl
FIGURE 3.
￿
Anti-CD4 mAbs specifically inhibit antigen responses by CD4' transfected BI-141
cells. T hybridoma cells were stimulated with FT5.7 cells pulsed with 100 hg/ml beef insulin.
For each cell line IL-2 release is shown for cultures containing either no antibody (lane 1) or
100 ng/ml ofanti-mCD4 (GK1.5) (lane 2), anti-hCD4 (OKT4B) (lane 3), anti-hCD4 (OKT4D)
(lane 4), or anti-I-Ak (810-2.16) (lane 5) mAbs. Incubation conditions and IL-2 release assays
were as described in Materials and Methods.9P120 .4 1 .3 4 12
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FIGURE 4.
￿
HIV-1 envelope glycopro-
tein gpl20inhibits theIL-2 production
of BI-141 cells expressing hCD4. BI-
T4.D3 (a, b) and BI-L3T4D.B3 (c, d)
cells were analyzed for their response
against FT5.7 cells pre-incubated with
either 100kg/mlbeef insulin(a,c) (p)
or 500Wg/ml pork insulin (b, d) (7).
Inhibition wasperformedwith several
dilutions of recombinant gp120 (O);
mAbs OKT4B("), OKT4D ([I), or
GK1.5 (A); or sCD4 (E) at the indi-
catedconcentrations. sCD4 (50pg/ml)
wasalso analyzed in combination with
gp120(12 wg/ml) (A). IL-2 assaycon-
ditionswere as describedin Materials
and Methods.
inhibit responses by thehCD4 transfectants (data not shown). In contrast, transfec-
tants expressing mCD4 could only be inhibited by mAb GK1.5, and not by mAbs
specific for hCD4 (Figs. 3 and 4). In all cases complete inhibition of antigen re-
sponses was observed in the presence of mAb H10-2.16 (11), which recognizes the
Agk polypeptide chain and therefore interferes directly with antigen presentation
to BI-141 cells (Fig. 3).
SpeckBlocking ofhCD4 Transfectants by gp120.
￿
We could furtherdemonstrate the
specificity of the enhanced responses seen in hCD4 transfectants by taking advan-
tage of the finding that hCD4 serves as the cell surface receptor used by HIV-1 for
entry into human cells (8, 21-23). In vitro infection of CD4* cells by HIV-1 can
be inhibited by mAbs specific forhCD4 (21, 22), and hCD4 has been shown to bind
to gp120, the exterior envelope glycoprotein of HIV-1 (8). Notably, mCD4 does not
bind to gp120 (9) despite its homology to hCD4 (20). Soluble gp120 has been shown
to blockthehCD4-dependent increase in IL-2 secretionof a human class II-specific
mouse T cell hybridoma transfected with hCD4 (24).
We therefore examined whether soluble gp120 similarly inhibits the enhanced re-
sponses seen in hCD4-transfected BI-141 cells. As shown in Fig. 4, addition of 12
jug/ml of soluble gp120 completely inhibited the response of the hCD4-transfected
linesto pork insulin and blocked the response to beefinsulinto adegree comparable
to that seen with mAbs specific for hCD4. In contrast, the same concentration of
gp120 had no effect upon the mCD4-transfected lines (Fig. 4). As first shown by1884 EQUIVALENCE OF HUMAN AND MOUSE CD4 IN A MOUSE SYSTEM
Smith et al. (14), genetically engineered soluble forms ofhCD4 can bind gp120 and
block infection by HIV1. We therefore examined the effect ofsoluble recombinant
CD4 (sCD4) on the gpl20-dependent inhibition of our hCD4 transfectants. The
presence ofsCD4abrogated the inhibitory effect ofgp120(Fig. 4). Addition ofsCD4
alone did not inhibit IL-2 responses to either beefor pork insulin, suggesting that
the affinityofsCD4 for gp120 is much higher than its affinity for cell surface mouse
class II molecules.
Discussion
Human and mouse CD4 have each been shown to enhance T cell responses to
antigen by interactingwith human andmouse class II MHC molecules, respectively
(3-7, 25-27). Early studies by Swain et al. (28) first suggested the possibility that
hCD4 might be able to interact with mouse class II molecules. They found that
human cytotoxic T cells specific for mouse class II molecules expressed hCD4 and
were blockable by anti-hCD4 mAb. However, one could argue that this inhibition
byanti-hCD4 mAb resulted from steric interference withthe TCR, or possiblyfrom
transmission ofa negative signal to the T cell. Furthermore, any potential interac-
tions between the TCR and hCD4 were strictly syngeneic in the studies of Swain
et al. (28). In contrast, the results presented here demonstrate in a direct fashion
that addition ofhCD4 can enhance mouseT cell responsiveness to peptide antigens
bound to mouse class II molecules. These results in no way imply that the converse
is true, i.e., that mCD4 can interact with human class II. Indeed binding studies
have shown only poor binding between mCD4 transfectants and human B cells ex-
pressing class II proteins (29). Studies by Gay et al. (25) and by Sleckman et al.
(26) have both previously shown that hCD4 can function in mouse T cells; however,
in contrast to our system, the ligand forhCD4 was human and not mouse class II.
We havebeen unable to detect differences between theeffects ofmCD4 andhCD4
upon the response oftransfected BI-141 cellsto either beefor pork insulin presented
bymouse class II molecules. In contrast, gp120 only bindsto hCD4 and not mCD4,
indicating that the binding site on CD4 for class II MHC proteins must be distinct
from that for gpl20. This conclusion is supported by recent studies showing that
mutations not only in the gp120 binding site, but also in other regions ofthe hCD4
protein, affect the ability of hCD4-transfected COS-1 cells to bind human B cells
that express class II molecules (29).
Summary
We have examined the ability ofhCD4 to interact functionally with mouse class
II MHC molecules using the mouse Tcell hybridoma BI-141, specific for beef in-
sulin. We have previously shown that expression ofmouse CD4 results in a marked
enhancementofIL-2 release by BI-141 cells in responseto beefinsulinor, in across-
reactiveresponse, topork insulin, onthe appropriate mouse APCs. We nowdemon-
strate that expression ofhCD4 results in an equivalent stimulation of antigen re-
sponsesby this mouseTcellhybridoma. The specificityofthiseffect wasdemonstrated
by mAb and gp120 blocking studies. These data provide the first direct evidence
for function of hCD4 and in an exclusively mouse system.We are grateful to Angelika Reske-Kunz and Wolfgang Ballhausen for the BI-141 T cell hy-
bridoma, Ronald Germain for Ac,bAok-transfected L cells, Tim Mossman for HT-2 cells,
Genentech Inc. for soluble gpl20and soluble CD4, Becton Dickinson & Co. for purified Leu-
3a mAb, Patricia Rao for purified OKT4B and OKT4D mAbs, and Cetus Corp. for recom-
binant human IL-2 (30, 31).
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